Market Cap 730.26M
Revenue (ttm) 500.19M
Net Income (ttm) 32.17M
EPS (ttm) N/A
PE Ratio 14.25
Forward PE 13.60
Profit Margin 6.43%
Debt to Equity Ratio 0.00
Volume 416,500
Avg Vol 442,222
Day's Range N/A - N/A
Shares Out 36.51M
Stochastic %K 57%
Beta 0.58
Analysts Strong Sell
Price Target $33.17

Company Profile

EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. The company offers automotive, and home and renters insurance, as well as campaign management tools. The company serves insurance carriers and agents, and indirect distributors. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Industry: Internet Content & Information
Sector: Communication Services
Phone: 855 522 3444
Address:
141 Portland Street, Cambridge, United States
margingod
margingod Oct. 23 at 4:46 PM
$EVER undervalued as fuck
0 · Reply
ZacksResearch
ZacksResearch Oct. 14 at 2:48 PM
$EVER: Is the premium valuation justified? Despite a Zacks Rank #3 (Hold) and a year-over-year increase of 48.8% in projected EPS for 2025, EverQuote shares trade at a pricey 4.32x price-to-book, well above the industry average. Yet, the average analyst price target suggests a 50.7% upside potential. See what makes the investment case strong for EVER 👉 https://www.zacks.com/stock/news/2768280/ever-outperforms-industry-trades-at-premium-how-to-play-the-stock?cid=sm-stocktwits-2-2768280-body-15937&ADID=SYND_STOCKTWITS_TWEET_2_2768280_BODY_15937
0 · Reply
ZacksResearch
ZacksResearch Oct. 14 at 1:48 PM
$EVER outperforming its peers — but is the premium justified? The company’s edge comes from its exclusive data asset, tech-driven approach, and renewed focus on core P&C markets — all backed by a solid financial profile. Find out how to play the stock here 👉 https://www.zacks.com/stock/news/2768280/ever-outperforms-industry-trades-at-premium-how-to-play-the-stock?cid=sm-stocktwits-2-2768280-teaser-15915&ADID=SYND_STOCKTWITS_TWEET_2_2768280_TEASER_15915
0 · Reply
Ersttr3der
Ersttr3der Oct. 13 at 7:52 PM
$EVER tome to swing trade🤑🤑🥰
0 · Reply
Bangra
Bangra Oct. 13 at 7:43 PM
0 · Reply
Ersttr3der
Ersttr3der Oct. 13 at 7:22 PM
$EVER ouch wtf is happening to this🤣🤣
1 · Reply
Briguy1
Briguy1 Oct. 9 at 3:54 PM
$ROOT $HIPO Hippo is up over 120% for the year and for the past 6 months every dip has been bought back $900M market cap and no earnings $ROOT was following trend but for the last 6 months their paths diverged - both insuratech and both tracked each other for a long time _ I own both but more heavily weighted to ROOT - IMHO these companies should be tracking each other but they are not - - $PGR $ALLS own a little bit as well... $GSHD (do not own) has had their own problems over the last 18 months but I think that should turn around when the stock consolidates around $65+/- $EVER (do not own) has been sideways for a year and is trying to make up its mind...
0 · Reply
Clotho
Clotho Sep. 24 at 12:33 PM
$EVER I started a position here this past week. I will look to add more when it makes sense to round out my long position.
0 · Reply
JosephPacheco392
JosephPacheco392 Sep. 21 at 12:20 PM
$EVER Biotech with clinical catalyst. High risk speculation. Trading near cash value. No pattern.
1 · Reply
ZacksResearch
ZacksResearch Sep. 19 at 7:16 PM
$EVER vs. $ROOT — which insurtech stock wins the race? EverQuote is debt-free and leaning on an AI-powered platform, stacking up favorably against Root’s position. Full breakdown here 👉 https://www.zacks.com/stock/news/2754312/root-vs-everquote-which-stock-is-the-stronger-bet-in-insurtech?cid=sm-stocktwits-2-2754312-teaser-13386&ADID=SYND_STOCKTWITS_TWEET_2_2754312_TEASER_13386
1 · Reply
Latest News on EVER
EverQuote to Present at Upcoming Investor Conferences

Aug 5, 2025, 4:10 PM EDT - 2 months ago

EverQuote to Present at Upcoming Investor Conferences


EverQuote: New Buybacks Signal A Very Healthy Business

Aug 5, 2025, 11:38 AM EDT - 2 months ago

EverQuote: New Buybacks Signal A Very Healthy Business


EverQuote, Inc. (EVER) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 9:07 PM EDT - 2 months ago

EverQuote, Inc. (EVER) Q2 2025 Earnings Call Transcript


EverQuote Announces Second Quarter 2025 Financial Results

Aug 4, 2025, 4:10 PM EDT - 2 months ago

EverQuote Announces Second Quarter 2025 Financial Results


EverQuote: Diversification Could Provide More Upside

Aug 2, 2025, 3:05 AM EDT - 2 months ago

EverQuote: Diversification Could Provide More Upside


EverQuote: Stock With Above-Average Gain Potential

May 12, 2025, 4:55 AM EDT - 5 months ago

EverQuote: Stock With Above-Average Gain Potential


EverQuote: Auto Insurance Carriers Are Still Revving Up Growth

May 6, 2025, 7:45 AM EDT - 6 months ago

EverQuote: Auto Insurance Carriers Are Still Revving Up Growth


EverQuote, Inc. (EVER) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:13 PM EDT - 6 months ago

EverQuote, Inc. (EVER) Q1 2025 Earnings Call Transcript


EverQuote Announces First Quarter 2025 Financial Results

May 5, 2025, 4:05 PM EDT - 6 months ago

EverQuote Announces First Quarter 2025 Financial Results


EverQuote Attracts Big Money, Eyes Growth

Mar 28, 2025, 6:59 AM EDT - 7 months ago

EverQuote Attracts Big Money, Eyes Growth


EverQuote, Inc. (EVER) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 7:58 PM EST - 8 months ago

EverQuote, Inc. (EVER) Q4 2024 Earnings Call Transcript


EverQuote: Ripe Buying Moment (Rating Upgrade)

Dec 12, 2024, 1:16 AM EST - 11 months ago

EverQuote: Ripe Buying Moment (Rating Upgrade)


EverQuote to Participate in Upcoming Investor Conferences

Nov 7, 2024, 4:10 PM EST - 1 year ago

EverQuote to Participate in Upcoming Investor Conferences


EverQuote, Inc. (EVER) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 9:26 PM EST - 1 year ago

EverQuote, Inc. (EVER) Q3 2024 Earnings Call Transcript


EverQuote: Driving In The Right Lane Again (Rating Upgrade)

Sep 22, 2024, 8:18 AM EDT - 1 year ago

EverQuote: Driving In The Right Lane Again (Rating Upgrade)


EverQuote, Inc. (EVER) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 3:34 AM EDT - 1 year ago

EverQuote, Inc. (EVER) Q2 2024 Earnings Call Transcript


EverQuote, Inc. (EVER) Q1 2024 Earnings Call Transcript

May 6, 2024, 10:14 PM EDT - 1 year ago

EverQuote, Inc. (EVER) Q1 2024 Earnings Call Transcript


EverQuote Announces First Quarter 2024 Financial Results

May 6, 2024, 4:05 PM EDT - 1 year ago

EverQuote Announces First Quarter 2024 Financial Results


EverQuote, Inc. (EVER) Q4 2023 Earnings Call Transcript

Feb 26, 2024, 10:10 PM EST - 1 year ago

EverQuote, Inc. (EVER) Q4 2023 Earnings Call Transcript


EverQuote, Inc. (EVER) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 7:55 PM EST - 2 years ago

EverQuote, Inc. (EVER) Q3 2023 Earnings Call Transcript


EverQuote Announces Third Quarter 2023 Financial Results

Nov 6, 2023, 4:05 PM EST - 2 years ago

EverQuote Announces Third Quarter 2023 Financial Results


EverQuote Inc. (EVER) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 8:40 PM EDT - 2 years ago

EverQuote Inc. (EVER) Q2 2023 Earnings Call Transcript


EverQuote Announces Second Quarter 2023 Financial Results

Aug 7, 2023, 4:05 PM EDT - 2 years ago

EverQuote Announces Second Quarter 2023 Financial Results


EverQuote Approaches Operating Breakeven As It Diversifies

Jun 2, 2023, 1:45 PM EDT - 2 years ago

EverQuote Approaches Operating Breakeven As It Diversifies


EverQuote, Inc. (EVER) Q1 2023 Earnings Call Transcript

May 8, 2023, 6:57 PM EDT - 2 years ago

EverQuote, Inc. (EVER) Q1 2023 Earnings Call Transcript


EverQuote, Inc. (EVER) Q4 2022 Earnings Call Transcript

Feb 27, 2023, 10:22 PM EST - 2 years ago

EverQuote, Inc. (EVER) Q4 2022 Earnings Call Transcript


margingod
margingod Oct. 23 at 4:46 PM
$EVER undervalued as fuck
0 · Reply
ZacksResearch
ZacksResearch Oct. 14 at 2:48 PM
$EVER: Is the premium valuation justified? Despite a Zacks Rank #3 (Hold) and a year-over-year increase of 48.8% in projected EPS for 2025, EverQuote shares trade at a pricey 4.32x price-to-book, well above the industry average. Yet, the average analyst price target suggests a 50.7% upside potential. See what makes the investment case strong for EVER 👉 https://www.zacks.com/stock/news/2768280/ever-outperforms-industry-trades-at-premium-how-to-play-the-stock?cid=sm-stocktwits-2-2768280-body-15937&ADID=SYND_STOCKTWITS_TWEET_2_2768280_BODY_15937
0 · Reply
ZacksResearch
ZacksResearch Oct. 14 at 1:48 PM
$EVER outperforming its peers — but is the premium justified? The company’s edge comes from its exclusive data asset, tech-driven approach, and renewed focus on core P&C markets — all backed by a solid financial profile. Find out how to play the stock here 👉 https://www.zacks.com/stock/news/2768280/ever-outperforms-industry-trades-at-premium-how-to-play-the-stock?cid=sm-stocktwits-2-2768280-teaser-15915&ADID=SYND_STOCKTWITS_TWEET_2_2768280_TEASER_15915
0 · Reply
Ersttr3der
Ersttr3der Oct. 13 at 7:52 PM
$EVER tome to swing trade🤑🤑🥰
0 · Reply
Bangra
Bangra Oct. 13 at 7:43 PM
0 · Reply
Ersttr3der
Ersttr3der Oct. 13 at 7:22 PM
$EVER ouch wtf is happening to this🤣🤣
1 · Reply
Briguy1
Briguy1 Oct. 9 at 3:54 PM
$ROOT $HIPO Hippo is up over 120% for the year and for the past 6 months every dip has been bought back $900M market cap and no earnings $ROOT was following trend but for the last 6 months their paths diverged - both insuratech and both tracked each other for a long time _ I own both but more heavily weighted to ROOT - IMHO these companies should be tracking each other but they are not - - $PGR $ALLS own a little bit as well... $GSHD (do not own) has had their own problems over the last 18 months but I think that should turn around when the stock consolidates around $65+/- $EVER (do not own) has been sideways for a year and is trying to make up its mind...
0 · Reply
Clotho
Clotho Sep. 24 at 12:33 PM
$EVER I started a position here this past week. I will look to add more when it makes sense to round out my long position.
0 · Reply
JosephPacheco392
JosephPacheco392 Sep. 21 at 12:20 PM
$EVER Biotech with clinical catalyst. High risk speculation. Trading near cash value. No pattern.
1 · Reply
ZacksResearch
ZacksResearch Sep. 19 at 7:16 PM
$EVER vs. $ROOT — which insurtech stock wins the race? EverQuote is debt-free and leaning on an AI-powered platform, stacking up favorably against Root’s position. Full breakdown here 👉 https://www.zacks.com/stock/news/2754312/root-vs-everquote-which-stock-is-the-stronger-bet-in-insurtech?cid=sm-stocktwits-2-2754312-teaser-13386&ADID=SYND_STOCKTWITS_TWEET_2_2754312_TEASER_13386
1 · Reply
ZacksResearch
ZacksResearch Sep. 19 at 6:16 PM
$ROOT vs. $EVER — Why is EVER the better pick right now? 🤔 🌟 EVER holds a Zacks Rank #3 (Hold) while ROOT is stuck with a Zacks Rank #5 (Strong Sell). 📈 EVER’s 2025 EPS estimates imply a 30% increase YoY, and its strong cash flow is set to fuel AI investments. 💰 ROOT’s debt levels compare unfavorably with industry averages despite some operational gains. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2754312/root-vs-everquote-which-stock-is-the-stronger-bet-in-insurtech?cid=sm-stocktwits-2-2754312-body-13385&ADID=SYND_STOCKTWITS_TWEET_2_2754312_BODY_13385
1 · Reply
SIGNAL1
SIGNAL1 Sep. 19 at 2:26 PM
$EVER rate cut is good for this company but stock is not doing anything?
0 · Reply
ZacksResearch
ZacksResearch Sep. 11 at 5:41 PM
$EVER: Is a 39.86% upside based on analysts' average price target in sight? 🚀 EverQuote boasts a strong ROE of 36.9%, surpassing the industry's 14.8%, and analysts project 2026 earnings to rise 18.3% from 2025 estimates. However, its expensive valuation raises caution. See what makes the investment case strong for $EVER 👉 https://www.zacks.com/stock/news/2750352/ever-rallies-163-ytd-trades-at-premium-should-you-buy-the-stock?cid=sm-stocktwits-2-2750352-body-12092&ADID=SYND_STOCKTWITS_TWEET_2_2750352_BODY_12092
0 · Reply
ZacksResearch
ZacksResearch Sep. 11 at 4:41 PM
$EVER up 16.3% YTD — but is it worth the premium? 🚀 The company’s AI, data push and auto focus are fueling growth, yet rising costs, competition and regulatory risks can’t be ignored. Full bull vs. bear breakdown here 👉 https://www.zacks.com/stock/news/2750352/ever-rallies-163-ytd-trades-at-premium-should-you-buy-the-stock?cid=sm-stocktwits-2-2750352-teaser-12090&ADID=SYND_STOCKTWITS_TWEET_2_2750352_TEASER_12090
0 · Reply
BaselIIICompliantGroup
BaselIIICompliantGroup Aug. 27 at 4:31 AM
$EVER watching closely, price testing a key zone of interest.
0 · Reply
Joao_
Joao_ Aug. 24 at 2:31 PM
$EVER we have our side Point 72(0,44 millions shares). I believe it. I bought at 7,9😀.
0 · Reply
T_rader
T_rader Aug. 19 at 6:28 PM
$EVER when bottom?
0 · Reply
WOLFSTREET
WOLFSTREET Aug. 18 at 12:37 AM
$EVER I be huntin fur traysur darlin and I be looking rite hear.
0 · Reply
Estimize
Estimize Aug. 12 at 8:00 PM
Wall St is expecting 0.38 EPS for $EVER Q3 [Reporting 11/10 AMC] http://www.estimize.com/intro/ever?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Aug. 12 at 5:56 PM
$EVER is riding high above its 200-day SMA, but is it a buy? 📈 Despite a 43.2% upside potential to the $34 target, EVER's expensive valuation, rising expenses, regulatory risks, and competition pose challenges in a competitive market. ⚖️ Discover the full analysis here 👉 https://www.zacks.com/stock/news/2702925/everquote-trades-above-200-day-sma-time-to-buy-the-stock?cid=sm-stocktwits-2-2702925-body-7498&ADID=SYND_STOCKTWITS_TWEET_2_2702925_BODY_7498
0 · Reply
ZacksResearch
ZacksResearch Aug. 12 at 4:56 PM
$EVER back above its 200-day SMA — bullish signal or bull trap? Quote requests are climbing and returns look strong, but management still faces key challenges ahead. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2702925/everquote-trades-above-200-day-sma-time-to-buy-the-stock?cid=sm-stocktwits-2-2702925-teaser-7497&ADID=SYND_STOCKTWITS_TWEET_2_2702925_TEASER_7497
0 · Reply
Briguy1
Briguy1 Aug. 11 at 6:39 PM
$ROOT $GSHD $HIPO $LMND $EVER all up today…but $ROOT seems to be treading water
3 · Reply